Can a Smartphone-Personalized therapy curb suicidal thoughts?

NCT ID NCT07749391

Ongoing Symptom relief Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This trial tests a new, brief coaching program called PRECISE for young adults aged 18-26 who experience suicidal thoughts. Participants use a smartphone app to report their emotions and thoughts several times a day, and this personal data is used to tailor coaching sessions with coping skills and safety planning. The goal is to see if this personalized approach can reduce emotional distress and suicidal thoughts, and improve emotion regulation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PRECISE, a brief, personalized coaching intervention delivered via videoconferencing, using participants' own smartphone survey data to tailor coping skills and safety planning.
What this could lead to: If successful, this could lead to a more personalized, effective approach to reducing suicidal thoughts in young adults, potentially saving lives by addressing individual triggers.
What could go wrong: This is a small, early-stage pilot study, so results may not apply broadly. The intervention is brief and adjunctive, and its success depends on participant engagement and the accuracy of personalized data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL THOUGHTS AND BEHAVIORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior Emotional Regulation Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUICIDAL THOUGHTS AND BEHAVIORS

Contacts and locations

Locations

Stein Clinical Research Building

La Jolla, California, 92093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.